title: Screening of viral specific T-cell lines for HLA alloreactivity prior to adoptive immunotherapy may prevent GvHD.
authors.forename: Lloyd J A
authors.initials: LJ
authors.lastname: D'Orsogna
authors.forename: Dave L
authors.initials: DL
authors.lastname: Roelen
authors.forename: Ilias I N
authors.initials: II
authors.lastname: Doxiadis
authors.forename: Frans H J
authors.initials: FH
authors.lastname: Claas
mesh_terms: D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D002460:Cell Line; D006086:Graft vs Host Disease / Q000517:prevention & control*; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000009:adverse effects* / Q000379:methods; D014777:Virus Diseases / Q000276:immunology / Q000628:therapy*
chemical_list: D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II